Glucagon-like peptide-1 (GLP-1) receptor agonist therapy duration vs durability of weight loss
Texas Family Medicine Research Journal · 01.07.2026 · 1 (4)
DOI: 10.65738/001c.163395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Texas Family Medicine Research Journal, online erschienen am 01.07.2026. Verfasst von Revanth Poondla und 5 weiteren Autor:innen. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Introduction
Despite growing recognition and use for weight loss therapy, there is a need for further investigation into the long-term effects of GLP-1 RA therapy. Objective/Hypothesis: Using a retrospective cohort design, this study sought to ascertain whether there is a duration of therapy with GLP-1 RA after which weight loss is durable. We hypothesized that there would be a duration of therapy after which weight loss is more durable.
Methods
We conducted a retrospective study of de-identified electronic health record data to evaluate weight trajectories among adults initiated on semaglutide or tirzepatide between 2005 and 2025. Medication orders were grouped into discrete therapy courses, and weight measurements during treatment and within one year after cessation were linked to each course. The primary outcome was absolute and percent weight change approximately one year after discontinuation, analyzed by treatment duration using descriptive statistics and mixed-effects regression models.
Results
Patients treated for
Zitieren
APA
Poondla, R., Ngo, A., Zhang, C., Sharma, A., Minor, J., & Youens, K. (2026). Glucagon-like peptide-1 (GLP-1) receptor agonist therapy duration vs durability of weight loss. Texas Family Medicine Research Journal, 1(4). https://doi.org/10.65738/001c.163395
Vancouver
Poondla R, Ngo A, Zhang C, Sharma A, Minor J, Youens K. Glucagon-like peptide-1 (GLP-1) receptor agonist therapy duration vs durability of weight loss. Texas Family Medicine Research Journal. 2026;1(4). doi:10.65738/001c.163395
BibTeX
@article{Poondla2026,
author = {Poondla, Revanth and Ngo, Andy and Zhang, Chelsea and Sharma, Anuj and Minor, Jacob and Youens, Kenneth},
title = {Glucagon-like peptide-1 (GLP-1) receptor agonist therapy duration vs durability of weight loss},
journal = {Texas Family Medicine Research Journal},
year = {2026},
volume = {1},
number = {4},
doi = {10.65738/001c.163395}
}
EUVIMED